Jane Street Group LLC bought a new stake in West Pharmaceutical Services, Inc. (NYSE:WST) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 5,400 shares of the medical instruments supplier’s stock, valued at approximately $520,000.

Other large investors have also recently modified their holdings of the company. The Manufacturers Life Insurance Company increased its stake in West Pharmaceutical Services by 2.3% in the second quarter. The Manufacturers Life Insurance Company now owns 108,158 shares of the medical instruments supplier’s stock valued at $10,223,000 after purchasing an additional 2,427 shares in the last quarter. American Century Companies Inc. increased its stake in West Pharmaceutical Services by 0.4% in the second quarter. American Century Companies Inc. now owns 701,364 shares of the medical instruments supplier’s stock valued at $66,293,000 after purchasing an additional 2,605 shares in the last quarter. State Board of Administration of Florida Retirement System increased its stake in West Pharmaceutical Services by 16.7% in the second quarter. State Board of Administration of Florida Retirement System now owns 88,252 shares of the medical instruments supplier’s stock valued at $8,342,000 after purchasing an additional 12,609 shares in the last quarter. CIBC Asset Management Inc bought a new stake in West Pharmaceutical Services in the second quarter valued at approximately $223,000. Finally, Chatham Capital Group Inc. increased its stake in West Pharmaceutical Services by 7.8% in the second quarter. Chatham Capital Group Inc. now owns 17,300 shares of the medical instruments supplier’s stock valued at $1,635,000 after purchasing an additional 1,245 shares in the last quarter. 93.28% of the stock is owned by hedge funds and other institutional investors.

In related news, CFO William J. Federici sold 21,000 shares of the stock in a transaction on Friday, December 8th. The shares were sold at an average price of $99.01, for a total transaction of $2,079,210.00. Following the completion of the transaction, the chief financial officer now owns 190,493 shares in the company, valued at $18,860,711.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.90% of the stock is owned by corporate insiders.

Several research analysts have recently weighed in on WST shares. Jefferies Group upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and upped their price target for the company from $96.00 to $115.00 in a report on Friday, September 15th. Bank of America cut shares of West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 price target for the company. in a report on Tuesday, October 17th. Wells Fargo & Company upped their price target on shares of West Pharmaceutical Services from $105.00 to $112.00 and gave the company an “outperform” rating in a report on Friday, October 27th. Zacks Investment Research upgraded shares of West Pharmaceutical Services from a “sell” rating to a “hold” rating in a report on Wednesday, September 27th. Finally, Stephens started coverage on shares of West Pharmaceutical Services in a report on Tuesday, October 3rd. They issued an “equal weight” rating and a $99.00 price target for the company. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company’s stock. West Pharmaceutical Services has an average rating of “Hold” and an average target price of $106.00.

West Pharmaceutical Services, Inc. (NYSE WST) traded up $0.49 during trading on Friday, hitting $98.73. 417,937 shares of the stock traded hands, compared to its average volume of 261,889. The firm has a market capitalization of $7,331.00, a PE ratio of 42.56, a PEG ratio of 2.11 and a beta of 1.11. West Pharmaceutical Services, Inc. has a 12 month low of $77.97 and a 12 month high of $103.36. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.59 and a quick ratio of 1.87.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings results on Thursday, October 26th. The medical instruments supplier reported $0.67 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.14. The company had revenue of $398.20 million during the quarter, compared to analysts’ expectations of $386.02 million. West Pharmaceutical Services had a net margin of 12.12% and a return on equity of 14.47%. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.53 earnings per share. equities research analysts forecast that West Pharmaceutical Services, Inc. will post 2.76 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Jane Street Group LLC Invests $520,000 in West Pharmaceutical Services, Inc. (WST) Stock” was first reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.watchlistnews.com/jane-street-group-llc-invests-520000-in-west-pharmaceutical-services-inc-wst-stock/1769778.html.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.